Vives F
Cited by
Cited by
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide‐induced multiple organ dysfunction syndrome in rats
E Crespo, M Macías, D Pozo, G Escames, M Martín, F Vives, JM Guerrero, ...
The FASEB Journal 13 (12), 1537-1546, 1999
Minireview: cell protective role of melatonin in the brain
D Acufla‐Castroviejo, G Escames, M Macks, AM Hoyos, AM Carballo, ...
Journal of pineal research 19 (2), 57-63, 1995
Electrophysiological study of the response of medial prefrontal cortex neurons to stimulation of the basolateral nucleus of the amygdala in the rat
JM Perez-Jaranay, F Vives
Brain research 564 (1), 97-101, 1991
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
FJ Barrero, I Ampuero, B Morales, F Vives, J de Dios Luna Del Castillo, ...
The pharmacogenomics journal 5 (2), 135-141, 2005
Comparative effects of melatonin, l‐deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro
H Khaldy, G Escames, J Leon, F Vives, JD Luna, D Acuna‐Castroviejo
Journal of pineal research 29 (2), 100-107, 2000
Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
R Duran, FJ Barrero, B Morales, JD Luna, M Ramirez, F Vives
Movement disorders 25 (4), 489-493, 2010
Electrophysiological evidence that the mediodorsal nucleus of the thalamus is a relay between the ventral pallidum and the medial prefrontal cortex in the rat
F Vives, GJ Mogenson
Brain Research 344 (2), 329-337, 1985
Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives
J Leon, F Vives, E Crespo, E Camacho, A Espinosa, MLA Gallo, ...
Journal of neuroendocrinology 10 (4), 297-302, 1998
Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa
A Agil, R Durán, F Barrero, B Morales, M Araúzo, F Alba, MT Miranda, ...
Journal of the neurological sciences 240 (1-2), 31-36, 2006
Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole‐induced seizures
L Bikjdaouene, G Escames, J Leon, JMR Ferrer, H Khaldy, F Vives, ...
Journal of pineal research 35 (1), 54-60, 2003
Calcium‐dependent effects of melatonin inhibition of glutamatergic response in rat striatum
G Escames, M Macias, J Leon, J Garcia, H Khaldy, M Martin, F Vives, ...
Journal of neuroendocrinology 13 (5), 459-466, 2001
Beta-endorphin and ACTH in plasma: Effects of physical and psychological stress
CM Oltras, F Mora, F Vives
Life Sciences 40 (17), 1683-1686, 1987
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ...
Movement Disorders 34 (4), 460-468, 2019
Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ...
JAMA neurology 78 (4), 464-472, 2021
Neuropeptides, neuropeptidases and brain asymmetry
M Ramírez, I Prieto, F Vives, M de Gasparo, F Alba
Current Protein and Peptide Science 5 (6), 497-506, 2004
Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat.
G Escames, F Vives
Neuroreport 7 (2), 597-600, 1996
Brain aminopeptidases and hypertension
I Banegas, I Prieto, F Vives, F Alba, M de Gasparo, AB Segarra, ...
Journal of the Renin-Angiotensin-Aldosterone System 7 (3), 129-134, 2006
Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome
KR Kessler, N Hamscho, B Morales, C Menzel, F Barrero, F Vives, ...
Journal of neural transmission 112, 1345-1353, 2005
Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ...
Movement Disorders 35 (5), 774-780, 2020
The system can't perform the operation now. Try again later.
Articles 1–20